The filoviruses Ebola and Marburg use several different and effective mechanisms to both evade and battle the immune system. This Review explores recent findings in the filovirus–host-defence ...

Island will now focus on using the FDA’s animal rule to advance the Galidesivir program towards a new drug application (NDA), ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a sharehold ...

The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...

Island fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ viruses Island Pharmaceuticals has signed an asset purchase agreement to buy the Galidesivir ...

Island fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ viruses Island Pharmaceuticals has signed an asset purchase agreement to buy the Galidesivir ...

Island fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ viruses Island Pharmaceuticals has signed an asset purchase agreement to buy the Galidesivir ...

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic ...